Literature DB >> 12206661

Structural basis of phospholipase A2 inhibition for the synthesis of prostaglandins by the plant alkaloid aristolochic acid from a 1.7 A crystal structure.

Vikas Chandra1, Jayasankar Jasti, Punit Kaur, A Srinivasan, Ch Betzel, T P Singh.   

Abstract

This is the first structural observation of a plant product showing high affinity for phospholipase A(2) and regulating the synthesis of arachidonic acid, an intermediate in the production of prostaglandins. The crystal structure of a complex formed between Vipera russelli phospholipase A(2) and a plant alkaloid aristolochic acid has been determined and refined to 1.7 A resolution. The structure contains two crystallographically independent molecules of phospholipase A(2) in the form of an asymmetric dimer with one molecule of aristolochic acid bound to one of them specifically. The most significant differences introduced by asymmetric molecular association in the structures of two molecules pertain to the conformations of their calcium binding loops, beta-wings, and the C-terminal regions. These differences are associated with a unique conformational behavior of Trp(31). Trp(31) is located at the entrance of the characteristic hydrophobic channel which works as a passage to the active site residues in the enzyme. In the case of molecule A, Trp(31) is found at the interface of two molecules and it forms a number of hydrophobic interactions with the residues of molecule B. Consequently, it is pulled outwardly, leaving the mouth of the hydrophobic channel wide open. On the other hand, Trp(31) in molecule B is exposed to the surface and moves inwardly due to the polar environment on the molecular surface, thus narrowing the opening of the hydrophobic channel. As a result, the aristolochic acid is bound to molecule A only while the binding site of molecule B is empty. It is noteworthy that the most critical interactions in the binding of aristolochic acid are provided by its OH group which forms two hydrogen bonds, one each with His(48) and Asp(49).

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12206661     DOI: 10.1021/bi0258593

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  10 in total

1.  Crystal structure of the complex formed between a group I phospholipase A2 and a naturally occurring fatty acid at 2.7 A resolution.

Authors:  Garima Singh; Jayasankar Jasti; K Saravanan; Sujata Sharma; Punit Kaur; A Srinivasan; Tej P Singh
Journal:  Protein Sci       Date:  2005-02       Impact factor: 6.725

2.  In silico identification of viper phospholipaseA2 inhibitors: validation by in vitro, in vivo studies.

Authors:  Amit Nargotra; Sujata Sharma; Mohd Iqbal Alam; Zabeer Ahmed; Asha Bhagat; Subhash Chander Taneja; Ghulam Nabi Qazi; Surrinder Koul
Journal:  J Mol Model       Date:  2011-03-01       Impact factor: 1.810

Review 3.  Plant-Derived Toxin Inhibitors as Potential Candidates to Complement Antivenom Treatment in Snakebite Envenomations.

Authors:  Asenate A X Adrião; Aline O Dos Santos; Emilly J S P de Lima; Jéssica B Maciel; Weider H P Paz; Felipe M A da Silva; Manuela B Pucca; Ana M Moura-da-Silva; Wuelton M Monteiro; Marco A Sartim; Hector H F Koolen
Journal:  Front Immunol       Date:  2022-05-09       Impact factor: 8.786

4.  Interactions of selected indole derivatives with phospholipase A₂: in silico and in vitro analysis.

Authors:  Kalarickal Vijayan Dileep; Chandran Remya; Ignatius Tintu; Madathilkovilakathu Haridas; Chittalakkottu Sadasivan
Journal:  J Mol Model       Date:  2013-01-13       Impact factor: 1.810

5.  Structure based design of compounds from natural sources for diabetes and inflammation.

Authors:  Sivasubramanian Suhitha; Krishnaswamy Gunasekaran; Devadasan Velmurugan
Journal:  Bioinformation       Date:  2012-11-23

6.  Structural Basis for the Inhibition of a Phospholipase A2-Like Toxin by Caffeic and Aristolochic Acids.

Authors:  Carlos A H Fernandes; Fábio Florença Cardoso; Walter G L Cavalcante; Andreimar M Soares; Maeli Dal-Pai; Marcia Gallacci; Marcos R M Fontes
Journal:  PLoS One       Date:  2015-07-20       Impact factor: 3.240

Review 7.  Snake venom PLA2s inhibitors isolated from Brazilian plants: synthetic and natural molecules.

Authors:  B M A Carvalho; J D L Santos; B M Xavier; J R Almeida; L M Resende; W Martins; S Marcussi; S Marangoni; R G Stábeli; L A Calderon; A M Soares; S L Da Silva; D P Marchi-Salvador
Journal:  Biomed Res Int       Date:  2013-09-22       Impact factor: 3.411

8.  Antioxidant and Antivenom Potential of an Essential Oil, 4-(2-Oxo-propyl)-cyclopentane-1,3-dione, and Allantoin Derived from the Polyherbal Combination of Aristolochia indica L. and Piper nigrum L.

Authors:  Dhivya Sivaraj; Ray J Butcher; Jerry P Jasinski; Saikumar Sathyanarayanan; Revathi Ponnusamy; Sreeja Puthanpura Sasidharan; Kasipandi Muniyandi; Parimelazhagan Thangaraj; Karuppusamy Arunachalam
Journal:  Evid Based Complement Alternat Med       Date:  2022-03-07       Impact factor: 2.629

Review 9.  Perspective on the Therapeutics of Anti-Snake Venom.

Authors:  Isabel Gómez-Betancur; Vedanjali Gogineni; Andrea Salazar-Ospina; Francisco León
Journal:  Molecules       Date:  2019-09-09       Impact factor: 4.411

Review 10.  The Search for Natural and Synthetic Inhibitors That Would Complement Antivenoms as Therapeutics for Snakebite Envenoming.

Authors:  José María Gutiérrez; Laura-Oana Albulescu; Rachel H Clare; Nicholas R Casewell; Tarek Mohamed Abd El-Aziz; Teresa Escalante; Alexandra Rucavado
Journal:  Toxins (Basel)       Date:  2021-06-29       Impact factor: 4.546

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.